Yeramian Patrick D (CIK 0001358266)

Latest company ownership

AMLX - Amylyx Pharmaceuticals, Inc.

Role: Chief Medical Officer

Shares held

205,605

Last filed at

Jan 11, 2024

Confidence Score

50.0

2025Q4

Confidence Score History

2023Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Jan 9, 2024	Jan 11, 2024	Amylyx Pharmaceuticals, Inc.	Chief Medical Officer	Sell	46.3	-2,812	-1.35%	✗	$45.9K
May 15, 2023	May 17, 2023	Amylyx Pharmaceuticals, Inc.	Chief Medical Officer	Sell	30.0	-11,965	-5.43%	✓	$347.4K
Apr 17, 2023	Apr 19, 2023	Amylyx Pharmaceuticals, Inc.	Chief Medical Officer	Sell	15.0	-49,579	-19.22%	✓	$1.5M
Mar 16, 2023	Mar 24, 2023	Amylyx Pharmaceuticals, Inc.	Chief Medical Officer	Sell	15.0	-45,460	-17.91%	✓	$1.7M
Mar 16, 2023	Mar 20, 2023	Amylyx Pharmaceuticals, Inc.	Chief Medical Officer	Sell	10.0	-45,460	-22.25%	✓	$1.7M
Jan 6, 2023	Jan 10, 2023	Amylyx Pharmaceuticals, Inc.	Chief Medical Officer	Buy	65.0	+2,034	0.50%	✓	$73.8K